|
G |
ACACA |
acetyl-CoA carboxylase alpha |
increases expression multiple interactions |
EXP |
Glucose results in increased expression of ACACA mRNA MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr12:38,580,916...38,875,067
Ensembl chr12:38,581,457...38,824,712
|
|
G |
FASN |
fatty acid synthase |
multiple interactions increases expression |
EXP |
MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
|
|
G |
GH1 |
growth hormone 1 |
multiple interactions |
EXP |
GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Glucose] |
CTD |
PMID:9185964 |
|
NCBI chr12:15,064,965...15,066,698
Ensembl chr12:15,064,909...15,066,696
|
|
G |
INS |
insulin |
multiple interactions increases transport |
EXP |
INS protein promotes the reaction [AZ 002 results in increased uptake of Glucose]; oxophenylarsine inhibits the reaction [INS protein results in increased transport of Glucose]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS protein] |
CTD |
PMID:8048502 PMID:8699633 PMID:20622751 |
|
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
|
|
G |
LOC102165256 |
V-type proton ATPase subunit G 1 pseudogene |
decreases expression |
EXP |
Glucose results in decreased expression of ATP6V1G1 mRNA |
CTD |
PMID:16313995 |
|
NCBI chr 7:19,272,032...19,272,926
|
|
G |
MLXIP |
MLX interacting protein |
increases expression multiple interactions |
EXP |
Glucose results in increased expression of MLXIP mRNA Glucose promotes the reaction [T0901317 results in increased expression of MLXIP mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr14:30,575,098...30,646,275
Ensembl chr14:30,577,661...30,646,243
|
|
G |
NOS2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
EXP |
Glucose results in increased expression of NOS2 protein Kangen-karyu inhibits the reaction [Glucose results in increased expression of NOS2 protein] |
CTD |
PMID:16949779 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
multiple interactions increases expression |
EXP |
T0901317 promotes the reaction [Glucose results in increased expression of NR1H3 mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr 2:15,315,283...15,336,785
Ensembl chr 2:15,315,282...15,334,820
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
EXP |
Glucose results in increased expression of PTGS2 protein Kangen-karyu inhibits the reaction [Glucose results in increased expression of PTGS2 protein] |
CTD |
PMID:16949779 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases transport |
EXP |
SLC2A1 protein results in increased transport of Glucose |
CTD |
PMID:12081571 |
|
NCBI chr 6:168,535,398...168,561,170
Ensembl chr 6:168,535,440...168,560,867
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions increases expression |
EXP |
MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
|
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
[Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein; Quercetin inhibits the reaction [[Antimycin A co-treated with Deoxyglucose] results in increased expression of BAX protein] |
CTD |
PMID:25087994 |
|
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
[Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein; Quercetin promotes the reaction [[Antimycin A co-treated with Deoxyglucose] results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:25087994 |
|
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
|
|
G |
NOS3 |
nitric oxide synthase 3 |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of NOS3 mRNA |
CTD |
PMID:11382920 |
|
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
increases expression multiple interactions |
EXP |
Glucose results in increased expression of ACACA mRNA MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr12:38,580,916...38,875,067
Ensembl chr12:38,581,457...38,824,712
|
|
G |
FASN |
fatty acid synthase |
multiple interactions increases expression |
EXP |
MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
|
|
G |
GH1 |
growth hormone 1 |
multiple interactions |
EXP |
GH1 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Glucose] |
CTD |
PMID:9185964 |
|
NCBI chr12:15,064,965...15,066,698
Ensembl chr12:15,064,909...15,066,696
|
|
G |
INS |
insulin |
multiple interactions increases transport |
EXP |
INS protein promotes the reaction [AZ 002 results in increased uptake of Glucose]; oxophenylarsine inhibits the reaction [INS protein results in increased transport of Glucose]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS protein] |
CTD |
PMID:8048502 PMID:8699633 PMID:20622751 |
|
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
|
|
G |
LOC102165256 |
V-type proton ATPase subunit G 1 pseudogene |
decreases expression |
EXP |
Glucose results in decreased expression of ATP6V1G1 mRNA |
CTD |
PMID:16313995 |
|
NCBI chr 7:19,272,032...19,272,926
|
|
G |
MLXIP |
MLX interacting protein |
increases expression multiple interactions |
EXP |
Glucose results in increased expression of MLXIP mRNA Glucose promotes the reaction [T0901317 results in increased expression of MLXIP mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of ACACA mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of FASN mRNA]; MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr14:30,575,098...30,646,275
Ensembl chr14:30,577,661...30,646,243
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP |
Kangen-karyu inhibits the reaction [Glucose results in increased expression of NOS2 protein] |
CTD |
PMID:16949779 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
multiple interactions increases expression |
EXP |
T0901317 promotes the reaction [Glucose results in increased expression of NR1H3 mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr 2:15,315,283...15,336,785
Ensembl chr 2:15,315,282...15,334,820
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
Kangen-karyu inhibits the reaction [Glucose results in increased expression of PTGS2 protein] |
CTD |
PMID:16949779 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases transport |
EXP |
SLC2A1 protein results in increased transport of Glucose |
CTD |
PMID:12081571 |
|
NCBI chr 6:168,535,398...168,561,170
Ensembl chr 6:168,535,440...168,560,867
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions increases expression |
EXP |
MLXIP protein affects the reaction [Glucose results in increased expression of SREBF1 mRNA] |
CTD |
PMID:25827716 |
|
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
|
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
EXP |
mogroside V inhibits the reaction [Particulate Matter results in increased expression of IL18 mRNA] |
CTD |
PMID:35134483 |
|
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
increases expression |
EXP |
mogroside V results in increased expression of IL1B mRNA |
CTD |
PMID:35134483 |
|
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
EXP |
mogroside V inhibits the reaction [Particulate Matter results in increased expression of NLRP3 protein] |
CTD |
PMID:35134483 |
|
NCBI chr 2:56,892,241...56,977,412
Ensembl chr 2:56,892,243...56,977,228
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
mogroside V inhibits the reaction [Particulate Matter results in increased expression of NOS2 mRNA] |
CTD |
PMID:35134483 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
mogroside V inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] |
CTD |
PMID:35134483 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
mogroside V inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein] |
CTD |
PMID:35134483 |
|
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
mogroside V inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA] |
CTD |
PMID:35134483 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
decreases expression |
EXP |
Neomycin results in decreased expression of SLC5A1 mRNA; Neomycin results in decreased expression of SLC5A1 protein |
CTD |
PMID:12927799 |
|
NCBI chr14:48,566,400...48,704,145
Ensembl chr14:48,628,224...48,705,841
|
|
|
G |
IL10 |
interleukin 10 |
decreases expression |
EXP |
notoginsenoside R1 results in decreased expression of IL10 protein |
CTD |
PMID:25721049 |
|
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL4 |
interleukin 4 |
decreases expression |
EXP |
notoginsenoside R1 results in decreased expression of IL4 protein |
CTD |
PMID:25721049 |
|
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
|
|